ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries.

TD Cowen adjusted its financial outlook for ICON plc (NASDAQ:ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology, and medical device industries.

https://www.tipranks.com/news/the-fly/icon-energy-prices-9-16m-units-at-1-31-in-upsized-public-offering Icon Energy (ICON) announced the pricing of its public ...